129 related articles for article (PubMed ID: 22738913)
21. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase C theta plays a fundamental role in different types of chronic colitis.
Nagahama K; Ogawa A; Shirane K; Shimomura Y; Sugimoto K; Mizoguchi A
Gastroenterology; 2008 Feb; 134(2):459-69. PubMed ID: 18155708
[TBL] [Abstract][Full Text] [Related]
23. Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis.
Simpson SJ; Mizoguchi E; Allen D; Bhan AK; Terhorst C
Eur J Immunol; 1995 Sep; 25(9):2618-25. PubMed ID: 7589135
[TBL] [Abstract][Full Text] [Related]
24. B cells that produce immunoglobulin E mediate colitis in BALB/c mice.
Hoving JC; Kirstein F; Nieuwenhuizen NE; Fick LC; Hobeika E; Reth M; Brombacher F
Gastroenterology; 2012 Jan; 142(1):96-108. PubMed ID: 21983080
[TBL] [Abstract][Full Text] [Related]
25. Blocking of IL-6 signaling pathway prevents CD4+ T cell-mediated colitis in a T(h)17-independent manner.
Noguchi D; Wakita D; Tajima M; Ashino S; Iwakura Y; Zhang Y; Chamoto K; Kitamura H; Nishimura T
Int Immunol; 2007 Dec; 19(12):1431-40. PubMed ID: 17981790
[TBL] [Abstract][Full Text] [Related]
26. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.
Totsuka T; Kanai T; Nemoto Y; Tomita T; Tsuchiya K; Sakamoto N; Okamoto R; Watanabe M
Eur J Immunol; 2008 May; 38(5):1275-86. PubMed ID: 18412161
[TBL] [Abstract][Full Text] [Related]
27. Increased immunosuppressive function of CD4(+)CD25(+)Foxp3(+)GITR+ T regulatory cells from NFATc2((-/-)) mice controls allergen-induced experimental asthma.
Karwot R; Übel C; Bopp T; Schmitt E; Finotto S
Immunobiology; 2012 Sep; 217(9):905-11. PubMed ID: 22317750
[TBL] [Abstract][Full Text] [Related]
28. IRF4 selectively controls cytokine gene expression in chronic intestinal inflammation.
Mudter J; Yu J; Amoussina L; Weigmann B; Hoffman A; Rücknagel K; Galle PR; Neurath MF
Arch Immunol Ther Exp (Warsz); 2009; 57(5):369-76. PubMed ID: 19693649
[TBL] [Abstract][Full Text] [Related]
29. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.
Neurath MF; Finotto S
Cytokine Growth Factor Rev; 2011 Apr; 22(2):83-9. PubMed ID: 21377916
[TBL] [Abstract][Full Text] [Related]
30. Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment.
Habtezion A; Toivola DM; Butcher EC; Omary MB
J Cell Sci; 2005 May; 118(Pt 9):1971-80. PubMed ID: 15840656
[TBL] [Abstract][Full Text] [Related]
31. Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction.
Katsurano M; Niwa T; Yasui Y; Shigematsu Y; Yamashita S; Takeshima H; Lee MS; Kim YJ; Tanaka T; Ushijima T
Oncogene; 2012 Jan; 31(3):342-51. PubMed ID: 21685942
[TBL] [Abstract][Full Text] [Related]
32. Colon lamina propria dendritic cells induce a proinflammatory cytokine response in lamina propria T cells in the SCID mouse model of colitis.
Drakes ML; Blanchard TG; Czinn SJ
J Leukoc Biol; 2005 Dec; 78(6):1291-300. PubMed ID: 16204624
[TBL] [Abstract][Full Text] [Related]
33. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
[TBL] [Abstract][Full Text] [Related]
34. Phosphatidylinositol 3-kinase gamma inhibition ameliorates inflammation and tumor growth in a model of colitis-associated cancer.
González-García A; Sánchez-Ruiz J; Flores JM; Carrera AC
Gastroenterology; 2010 Apr; 138(4):1374-83. PubMed ID: 20004201
[TBL] [Abstract][Full Text] [Related]
35. Role of IL-17A in the development of colitis-associated cancer.
Hyun YS; Han DS; Lee AR; Eun CS; Youn J; Kim HY
Carcinogenesis; 2012 Apr; 33(4):931-6. PubMed ID: 22354874
[TBL] [Abstract][Full Text] [Related]
36. Colitis-related public T cells are selected in the colonic lamina propria of IL-10-deficient mice.
Takahashi I; Matsuda J; Gapin L; DeWinter H; Kai Y; Tamagawa H; Kronenberg M; Kiyono H
Clin Immunol; 2002 Mar; 102(3):237-48. PubMed ID: 11890710
[TBL] [Abstract][Full Text] [Related]
37. Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation.
Takai A; Marusawa H; Minaki Y; Watanabe T; Nakase H; Kinoshita K; Tsujimoto G; Chiba T
Oncogene; 2012 Mar; 31(13):1733-42. PubMed ID: 21841819
[TBL] [Abstract][Full Text] [Related]
38. Stress response protein cirp links inflammation and tumorigenesis in colitis-associated cancer.
Sakurai T; Kashida H; Watanabe T; Hagiwara S; Mizushima T; Iijima H; Nishida N; Higashitsuji H; Fujita J; Kudo M
Cancer Res; 2014 Nov; 74(21):6119-28. PubMed ID: 25187386
[TBL] [Abstract][Full Text] [Related]
39. Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma.
Poutahidis T; Haigis KM; Rao VP; Nambiar PR; Taylor CL; Ge Z; Watanabe K; Davidson A; Horwitz BH; Fox JG; Erdman SE
Carcinogenesis; 2007 Dec; 28(12):2614-23. PubMed ID: 17724375
[TBL] [Abstract][Full Text] [Related]
40. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development.
Waldner MJ; Neurath MF
Semin Immunol; 2014 Feb; 26(1):75-9. PubMed ID: 24447345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
